Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 105,952,381 | reported | 18 Mar 2019 | tx 3+30,952,381 |
| Myovant Sciences Ltd. | 40,765,599 | reported | 04 Jun 2019 | tx 2+3,534,257 |
| Urovant Sciences Ltd. | 22,860,013 | reported | 19 Jun 2019 | tx 27+2,834,915 |
| Arbutus Biopharma Corp | 1,164,000 | reported | 12 Jan 2018 | tx 2+1,164,000 |
| AbCellera Biologics Inc. | 541,354 | reported | 12 Jun 2025 | tx 5+628,292 |
| BridgeBio Pharma, Inc. | 81,576 | reported | 18 Nov 2025 | tx 14+345,068−195,599 |
| Roivant Sciences Ltd. | 71,850 | reported | 15 Sept 2022 | tx 2+123,992 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 36,801 | 66.63 USD | |
| 18 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 30,993 | 66.05 USD | |
| 18 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 24,007 | 65.23 USD | |
| 17 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 3,798 | 67.06 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 6,589 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 8,425 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | AbCellera Biologics Inc. | 238,864 | 0.00 USD | deriv |
| 02 May 2025 | SALE | BridgeBio Pharma, Inc. | 100,000 | 38.50 USD | |
| 21 Jun 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 26,014 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | AbCellera Biologics Inc. | 163,934 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | BridgeBio Pharma, Inc. | 51,501 | 0.00 USD | deriv |
| 01 Dec 2022 | GRANT_AWARD | AbCellera Biologics Inc. | 47,231 | 0.00 USD | deriv |
| 15 Sept 2022 | GRANT_AWARD | Roivant Sciences Ltd. | 52,142 | 0.00 USD | |
| 15 Sept 2022 | GRANT_AWARD | Roivant Sciences Ltd. | 71,850 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | BridgeBio Pharma, Inc. | 104,921 | 0.00 USD | deriv |
| 30 Dec 2021 | PURCHASE | BridgeBio Pharma, Inc. | 1,500 | 14.30 USD | |
| 29 Dec 2021 | PURCHASE | BridgeBio Pharma, Inc. | 6,000 | 12.90 USD | |
| 03 Dec 2021 | PURCHASE | AbCellera Biologics Inc. | 86,938 | 14.02 USD | first after silenceanomaly |
| 17 Jun 2021 | GRANT_AWARD | BridgeBio Pharma, Inc. | 38,895 | 0.00 USD | deriv |
| 23 Jun 2020 | GRANT_AWARD | BridgeBio Pharma, Inc. | 101,223 | 0.00 USD | deriv |
| 18 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 6,706 | 8.21 USD | |
| 19 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 4,957 | 8.17 USD | |
| 17 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 6,541 | 8.53 USD | |
| 14 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,144 | 7.91 USD | |
| 13 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,367 | 7.95 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Dec 2021.